Review article: the management of autoimmune hepatitis beyond consensus guidelines

Area of Science:

• Hepatology
• Autoimmune Diseases
• Clinical Evidence

Background:

• Consensus guidelines for autoimmune hepatitis (AIH) often rely on low-quality evidence, leading to diagnostic and management uncertainties.
• Recommendations may be weak, contradictory, or absent at critical decision points in AIH care.

Purpose of the Study:

• Identify specific decision points in autoimmune hepatitis diagnosis and management where guidelines are weak or lacking.
• Review the existing evidence base to inform these critical decision-making processes in AIH.

Main Methods:

• Conducted a literature search using PubMed for articles on 'autoimmune hepatitis' (1972-2013).
• Included personal experience and relevant investigations to identify key contributions to AIH understanding.

Main Results:

• Significant portions of guidelines from major liver and gastroenterology associations are based on low-quality evidence (70% AASLD, 48% BSG).
• Key diagnostic uncertainties include timing of biopsy, recognizing fulminant disease, interpreting atypical histology, and differentiating AIH from drug-induced liver injury.
• Management uncertainties involve pre-treatment testing, treating asymptomatic disease, defining treatment endpoints, managing suboptimal responses, and using specific medications and surveillance.

Conclusions:

• Autoimmune hepatitis guidelines are characterized by numerous uncertainties in both diagnosis and management.
• Clinical decisions must carefully weigh available evidence against individual patient needs and circumstances.